KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Xylem (XYL) Payables (2016 - 2026)

Xylem has reported Payables over the past 17 years, most recently at $969.0 million for Q1 2026.

  • For Q1 2026, Payables rose 1.15% year-over-year to $969.0 million; the TTM value through Mar 2026 reached $969.0 million, up 1.15%, while the annual FY2025 figure was $1.0 billion, 0.7% up from the prior year.
  • Payables for Q1 2026 was $969.0 million at Xylem, down from $1.0 billion in the prior quarter.
  • Over five years, Payables peaked at $1.0 billion in Q2 2025 and troughed at $618.0 million in Q3 2022.
  • A 5-year average of $882.9 million and a median of $948.0 million in 2024 define the central range for Payables.
  • Biggest five-year swings in Payables: soared 52.59% in 2023 and later decreased 2.89% in 2024.
  • Year by year, Payables stood at $723.0 million in 2022, then skyrocketed by 33.89% to $968.0 million in 2023, then rose by 3.93% to $1.0 billion in 2024, then rose by 0.7% to $1.0 billion in 2025, then decreased by 4.34% to $969.0 million in 2026.
  • Business Quant data shows Payables for XYL at $969.0 million in Q1 2026, $1.0 billion in Q4 2025, and $968.0 million in Q3 2025.